Loading stock analysis…
Evidence Synthesis
Last synthesized: 22 Jul 2026, 13:30
Evidence Synthesis
EKAMLEA experienced a 100% increase in its margin, while its revenue growth rate accelerated to 68% year-over-year.
The stock's .93% decline in price followed a daily cadence, with 100 shares traded on . The close price dropped to .14 INR, down from 7.51 INR the previous day.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 100 % | -2,161.08 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | -2,161.08 % | 0 | ▼ |
| REVENUE_GROWTH_YOY | 68 % | — | - |
| PRICE_CHANGE_PERCENT | -4.927 % | — | - |
| DAILY_VOLUME | 100 shares | 3,103 | ▼ |
| CLOSE_PRICE | 7.14 INR | 7.51 | ▼ |